Section Arrow
ICCC.NASDAQ
- ImmuCell Corp
Quotes are at least 15-min delayed:2026/08/01 16:14 EDT
Regular Hours
Last
 11.21
+0.15 (+1.36%)
Day High 
11.35 
Prev. Close
11.06 
1-M High
12.1 
Volume 
10.15K 
Bid
10.82
Ask
11.43
Day Low
10.97 
Open
10.98 
1-M Low
9.93 
Market Cap 
100.06M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.1 
20-SMA 10.97 
50-SMA 10.32 
52-W High 12.1 
52-W Low 4.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.07/--
Enterprise Value
111.56M
Balance Sheet
Book Value Per Share
3.22
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
27.64M
Operating Revenue Per Share
1.73
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
REPLReplimune Group11.2+5.79+107.02%-- 
GOSSGossamer Bio0.1695-0.0088-4.94%-- 
JUNSJupiter Neurosciences Inc0.09-0.0075-7.69%-- 
KPTIKaryopharm Therapeutics Inc.1.92-5.09-72.61%-- 
IOVAIovance Biotherapeutics4.07-0.62-13.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against theprincipal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.